Reference number : 236-2016-2017-Q2-00024, amendment number : , agreement type : G, recipient legal name : Larrivee, Bruno, recipient country : CA, recipient province : QC, recipient city : Montréal, recipient postal code : H1T 2M4, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 573375.0, agreement start date : 2016-07-01, agreement end date : 2021-06-30, description english : Evaluation of the anti-angiogenic and neuroprotective effects of the BMP antagonist COCO for the treatment of neovascular ocular pathologies., description french : Evaluation of the anti-angiogenic and neuroprotective effects of the BMP antagonist COCO for the treatment of neovascular ocular pathologies., expected results english : nan, expected results french : nan, additional information english : Grant or Award spanning more than one fiscal year.
(2016-17 to 2021-22), additional information french : Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier.
(2016-17 à 2021-22), owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada